Durlobactam

CAS No. 1467829-71-5

Durlobactam( Durlobactam )

Catalog No. M12004 CAS No. 1467829-71-5

Durlobactam is a novel beta-lactamase inhibitor for treatment of resistant bacterial infections.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 2043 Get Quote
50MG 4122 Get Quote
100MG 5760 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Durlobactam
  • Note
    Research use only, not for human use.
  • Brief Description
    Durlobactam is a novel beta-lactamase inhibitor for treatment of resistant bacterial infections.
  • Description
    Durlobactam is a novel beta-lactamase inhibitor for treatment of resistant bacterial infections.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Durlobactam
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1467829-71-5
  • Formula Weight
    277.251
  • Molecular Formula
    C8H11N3O6S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=S(O)(ON1[C@]2([H])C=C(C)[C@@H](C(N)=O)[N@@](C2)C1=O)=O
  • Chemical Name
    (1R,2S,5R)-2-carbamoyl-3-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-en-6-yl hydrogen sulfate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Cefmenoxime hydrochl...

    Cefmenoxime hydrochloride is a third-generation cephalosporin antibiotic.

  • Elubiol

    Elubiol is a new broad-spectrum antifungal product of imidazole, which can inhibit the biosynthesis of fungal ergosterol and change the composition of other lipid compounds in the cell membrane. Elubiol is used for skin and hair care in subjects with oily skin or dandruff.

  • FSL 1

    TLR2/6 agonist (also a putative TLR10 ligand). Activates NF-κB. Induces pro-inflammatory cytokines including IL-8, IL-1β, CCL20 and TNF-α in vitro. Synergizes with IFNγ to induce CXCL10 release from melanoma cells.